X hits on this document

PDF document

Occupational interstitial lung disease - page 10 / 12





10 / 12


C.S. Glaze , L.S. Newman / Clin Chest Med 25 (2004) 467–478

exposed co-workers whenever a new case of occupa-

[16] Wright RS, Abraham JL, Harber P, Burnett BR, Morris

tional ILD is identified.

P, West P. Fatal asbestosis 50 years after brief high


[1] Beckett WS. Occupational respiratory diseases. N Engl J Med 2000;342:406–13. [2] Demedts M, Wells AU, Anto JM, Costabel U, Hubbard R, Cullinan P, et al. Interstitial lung diseases: an epidemiological overview. Eur Respir J Suppl 2001; 32:2s – 16s. [3] Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environ- mental exposure to dust. BMJ 1990;301:1015 –7. [4] Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996;347:284 – 9. [5] Hubbard R, Cooper M, Antoniak M, Venn A, Khan S, Johnston I, et al. Risk of cryptogenic fibrosing alveo- litis in metal workers. Lancet 2000;355:466–7. [6] Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis: epidemiologic ap- proaches to occupational exposure. Am J Respir Crit Care Med 1994;150:670– 5. [7] Baumgartner KB, Samet JM, Coultas DB, Stidley CA, Hunt WC, Colby TV, et al. Occupational and environ- mental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000;152:307 – 15. [8] Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994;150:967– 72. [9] Thomeer MJ, Costabe U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J Suppl 2001;32:114s– 8s. [10] Newman LS. Occupational illness. N Engl J Med 1995;333:1128 – 34. [11] Monso E, Tura JM, Marsal M, Morell F, Pujadas J, Morera J. Mineralogical microanalysis of idiopathic pulmonary fibrosis. Arch Environ Health 1990;45: 185 – 8. [12] Fireman E, Haimsky E, Noiderfer M, Priel I, Lerman Y. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:144 – 8. [13] Registry AfTSaD. Taking an exposure history: case studies in environmental medicine. Washington, DC: US Department of Health and Human Services; 2000. [14] Burge P. How to take an occupational exposure history relevant to lung disease. In: Hendrick D, Burge P, Beckett W, et al, editors. Occupational disorders of the lung. Philadelphia: WB Saunders; 2002. p. 25–32. [15] Levin JL, Frank AL, Williams MG, McConnell W, Suzuki Y, Dodson RF. Kaolinosis in a cotton mill worker. Am J Ind Med 1996;29:215–21.

intensity exposure in a vermiculite expansion plant. Am J Respir Crit Care Med 2002;165:1145– 9. [17] Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, et al. Radiographic abnormali- ties and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect 2003;111:1753– 9. [18] Stoeckle JD, Hardy HL, Weber AL. Chronic beryllium disease: long-term follow-up of sixty cases and selective review of the literature. Am J Med 1969;46: 545 – 61. [19] Akira M. Uncommon pneumoconioses: CT and patho- logic findings. Radiology 1995;197:403–9. [20] Skarote SJ, Banks DE. Clinical perspective of in- organic dusts, metals, and fumes exposures. Curr Opin Pulm Med 1997;3:209 – 14. [21] Redlich C. Pulmonary fibrosis and interstitial lung diseases. In: Harber P, Schenker M, Balmes J, editors. Occupational and environmental respiratory disease. St. Louis: CV Mosby; 1996. p. 216– 27. [22] Churg A. Mineralogic analysis of lung tissue. In: Hendrick D, Burge P, Beckett W, et al, editors. Occu- pational disorders of the lung. Philadelphia: WB Saun- ders; 2002. p. 535– 44. [23] Nemery B, Bast A, Behr J, Borm PJ, Bourke SJ, Camus PH, et al. Interstitial lung disease induced by exogenous agents: factors governing susceptibility. Eur Respir J Suppl 2001;32:30s– 42s. [24] Mossman BT, Churg A. Mechanisms in the pathogene- sis of asbestosis and silicosis. Am J Respir Crit Care Med 1998;157:1666– 80. [25] Robledo R, Mossman B. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol 1999;180:158– 66. [26] Gong Jr H. Uncommon causes of occupational inter- stitial lung diseases. Curr Opin Pulm Med 1996;2: 405 – 11. [27] Department of Health and Human Services. Health effects of occupational exposure to respirable crystal- line silica. Cincinnati: Department of Health and Human Services; 2002. [28] Becklake MR. Asbestos and other fiber-related diseases of the lungs and pleura: distribution and determinants in exposed populations. Chest 1991;100:248– 54. [29] Rutstein DD. The principle of the sentinel health event and its application to the occupational diseases. Arch Environ Health 1984;39:158. [30] Aldrich TE, Leaverton PE. Sentinel event strategies in environmental health. Annu Rev Public Health 1993;14:205 – 17. [31] Baker EL. Sentinel event notification system for occu- pational risks (SENSOR): the concept. Am J Public Health 1989;79(Suppl):18– 20. [32] Reilly MJ, Rosenman KD, Watt FC, Stanbury MJ, Valiante DJ, Helmus LE, et al. Silicosis surveillance: Michigan, New Jersey, Ohio, and Wisconsin, 1987– 1990. MMWR CDC Surveill Summ 1993;42:23– 8.

Document info
Document views18
Page views18
Page last viewedSun Oct 23 15:02:14 UTC 2016